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Abstract
The mammalian genome encodes seven guanylyl cyclases, GC-A to GC-G, that are homodimeric
transmembrane receptors activated by a diverse range of endogenous ligands. These enzymes convert
guanosine-5'-triphosphate to the intracellular second messenger cyclic guanosine-3',5'-monophosphate (cyclic
GMP). GC-A, GC-B and GC-C are expressed predominantly in the cardiovascular system, skeletal system and
intestinal epithelium, respectively. GC-D and GC-G are found in the olfactory neuropepithelium and Grueneberg
ganglion of rodents, respectively. GC-E and GC-F are expressed in retinal photoreceptors.
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This is a citation summary for Receptor guanylyl cyclase (RGC) family in the Guide to Pharmacology database
(GtoPdb). It exists purely as an adjunct to the database to facilitate the recognition of citations to and from the
database by citation analyzers. Readers will almost certainly want to visit the relevant sections of the database
which are given here under database links.
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http://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=1022
    Transmembrane guanylyl cyclases
    http://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=662
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        Receptors
                GC-A(Guanylyl cyclase-A)
                http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1747
                GC-B(Guanylyl cyclase-B)
                http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1748
                GC-C(Guanylyl cyclase-C)
                http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1750
                NPR-C(natriuretic peptide receptor 3)
                http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1749
                GC-D(Guanylyl cyclase-D)
                http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2898
                GC-E(Guanylyl cyclase-E)
                http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2031
                GC-F(Guanylyl cyclase-F)
                http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2899
                GC-G(Guanylyl cyclase-G)
                http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2900
    Nitric oxide (NO)-sensitive (soluble) guanylyl cyclase
    http://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=939
        Receptors
            Complexes
                GC-1(Guanylyl cyclase, α1β1)
                http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1287
                GC-2(Guanylyl cyclase, α2β1)
                http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2897
            Receptors and Subunits
                Guanylyl cyclase α1 subunit
                http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1288
                Guanylyl cyclase α2 subunit
                http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1289
                Guanylyl cyclase β1 subunit
                http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1290
                Guanylyl cyclase β2 subunit
                http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1291
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